159 related articles for article (PubMed ID: 21969114)
1. Mechanisms for endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Xie H
J Mol Neurosci; 2012 Jun; 47(2):408-17. PubMed ID: 21969114
[TBL] [Abstract][Full Text] [Related]
2. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886
[TBL] [Abstract][Full Text] [Related]
3. Role of RhoA/ROCK signaling in endothelial-monocyte-activating polypeptide II opening of the blood-tumor barrier: role of RhoA/ROCK signaling in EMAP II opening of the BTB.
Xie H; Xue YX; Liu LB; Liu YH; Wang P
J Mol Neurosci; 2012 Mar; 46(3):666-76. PubMed ID: 21647708
[TBL] [Abstract][Full Text] [Related]
4. Role of ATP synthase alpha subunit in low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier.
Li Z; Liu YH; Xue YX; Xie H; Liu LB
J Neurol Sci; 2011 Jan; 300(1-2):52-8. PubMed ID: 21035144
[TBL] [Abstract][Full Text] [Related]
5. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism.
Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB
Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443
[TBL] [Abstract][Full Text] [Related]
6. Endothelial-monocyte-activating polypeptide II increases blood-tumor barrier permeability by down-regulating the expression levels of tight junction associated proteins.
Xie H; Xue YX; Liu LB; Liu YH
Brain Res; 2010 Mar; 1319():13-20. PubMed ID: 20083091
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Increases Blood-Tumor Barrier Permeability by Activating the RhoA/ROCK/PI3K Signaling Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Jun; 59(2):193-202. PubMed ID: 26521255
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood-Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway.
Li Z; Liu XB; Liu YH; Xue YX; Liu J; Teng H; Xi Z; Yao YL
J Mol Neurosci; 2016 Feb; 58(2):153-61. PubMed ID: 26358039
[TBL] [Abstract][Full Text] [Related]
9. Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Liu J; Yao YL; Ma J
J Mol Neurosci; 2015 Sep; 57(1):11-20. PubMed ID: 26087743
[TBL] [Abstract][Full Text] [Related]
10. Low-dose endothelial monocyte-activating polypeptide-ii increases permeability of blood-tumor barrier by caveolae-mediated transcellular pathway.
Li Z; Liu YH; Xue YX; Liu LB; Wang P
J Mol Neurosci; 2014 Mar; 52(3):313-22. PubMed ID: 24526454
[TBL] [Abstract][Full Text] [Related]
11. Additive effect of low-frequency ultrasound and endothelial monocyte-activating polypeptide II on blood-tumor barrier in rats with brain glioma.
Zhang Z; Xue Y; Liu Y; Shang X
Neurosci Lett; 2010 Aug; 481(1):21-5. PubMed ID: 20600613
[TBL] [Abstract][Full Text] [Related]
12. The Role of miR-330-3p/PKC-α Signaling Pathway in Low-Dose Endothelial-Monocyte Activating Polypeptide-II Increasing the Permeability of Blood-Tumor Barrier.
Liu J; Liu L; Chao S; Liu Y; Liu X; Zheng J; Chen J; Gong W; Teng H; Li Z; Wang P; Xue Y
Front Cell Neurosci; 2017; 11():358. PubMed ID: 29311822
[TBL] [Abstract][Full Text] [Related]
13. Role of cAMP-dependent protein kinase A activity in low-dose endothelial monocyte-activating polypeptide-II-induced opening of blood-tumor barrier.
Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB
J Mol Neurosci; 2015 May; 56(1):60-9. PubMed ID: 25416651
[TBL] [Abstract][Full Text] [Related]
14. MiR-429 Regulated by Endothelial Monocyte Activating Polypeptide-II (EMAP-II) Influences Blood-Tumor Barrier Permeability by Inhibiting the Expressions of ZO-1, Occludin and Claudin-5.
Chen L; Xue Y; Zheng J; Liu X; Liu J; Chen J; Li Z; Xi Z; Teng H; Wang P; Liu L; Liu Y
Front Mol Neurosci; 2018; 11():35. PubMed ID: 29467620
[TBL] [Abstract][Full Text] [Related]
15. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
Liu LB; Xue YX; Liu YH; Wang YB
J Neurosci Res; 2008 Apr; 86(5):1153-68. PubMed ID: 18183615
[TBL] [Abstract][Full Text] [Related]
16. Functions for the cAMP/Epac/Rap1 Signaling Pathway in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier.
Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Yao YL; Ma J
J Mol Neurosci; 2015 Sep; 57(1):1-10. PubMed ID: 26044663
[TBL] [Abstract][Full Text] [Related]
17. Endothelial-monocyte-activating polypeptide II induces rat C6 glioma cell apoptosis via the mitochondrial pathway.
Liu LB; Xie H; Xue YX; Liu YH; Li Z; Wang P
Biochem Biophys Res Commun; 2015 Feb; 457(4):595-601. PubMed ID: 25600803
[TBL] [Abstract][Full Text] [Related]
18. Role of ROS/RhoA/PI3K/PKB signaling in NS1619-mediated blood-tumor barrier permeability increase.
Gu YT; Xue YX; Wang YF; Wang JH; ShangGuan QR; Zhang JX; Qin LJ
J Mol Neurosci; 2012 Sep; 48(1):302-12. PubMed ID: 22581438
[TBL] [Abstract][Full Text] [Related]
19. Interaction of the C-terminal domain of p43 and the alpha subunit of ATP synthase. Its functional implication in endothelial cell proliferation.
Chang SY; Park SG; Kim S; Kang CY
J Biol Chem; 2002 Mar; 277(10):8388-94. PubMed ID: 11741979
[TBL] [Abstract][Full Text] [Related]
20. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
Zhang Z; Xia C; Xue Y; Liu Y
J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
